<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <title>Thiamine - Medications - Offline Clinical Reference</title>
  <link rel="stylesheet" href="../style.css">
</head>
<body>
  <div class="topbar">
    <div class="topbar-inner">
      <span class="pill"><strong>Thiamine</strong></span>
      <span class="spacer"></span>
      <div class="nav-btns">
        <a class="btn small" href="../../index.html">Home</a>
        <a class="btn small" href="../../index.html#/sickbay-meds">Back to Medications</a>
      </div>
    </div>
  </div>

  <main class="wrap">
    <section class="section">
      <div class="kicker">Endocrine / Metabolic / Antidotes</div>
      <h1>Thiamine</h1>

      <div class="content">
        <h3>Stocked on board</h3>
        <ul>
          <li>Thiamine 100mg/mL Injection 1mL</li>
        </ul>

        <div class="rule"></div>

        <h3>Adult dosing</h3>
        <ul>
          <li><strong>Suspected Wernicke's encephalopathy / Wernicke-Korsakoff syndrome (acute presentation)</strong>
            <ul>
              <li>100 mg IV/IM immediately, then 100 mg IV/IM daily until normal diet resumed or no further improvement</li>
              <li>Some guidelines recommend higher doses (e.g., 200–500 mg TID IV) in confirmed/high-risk cases; follow local protocols or medical direction</li>
              <li>Administer BEFORE giving IV dextrose to prevent precipitating or worsening Wernicke's</li>
            </ul>
          </li>
          <li><strong>Suspected thiamine deficiency (non-emergent)</strong>
            <ul>
              <li>100 mg IM/IV daily for several days, followed by oral supplementation as available</li>
            </ul>
          </li>
          <li><strong>Prophylaxis in high-risk patients (e.g., chronic alcohol use, malnutrition, prolonged vomiting)</strong>
            <ul>
              <li>100 mg IM/IV prior to IV glucose administration when indicated</li>
            </ul>
          </li>
        </ul>

        <div class="rule"></div>

        <h3>Indications</h3>
        <ul>
          <li>Treatment or prevention of Wernicke's encephalopathy (altered mental status, ataxia, ophthalmoplegia in at-risk patients)</li>
          <li>Thiamine deficiency states (beriberi, chronic alcoholism, malnutrition, hyperemesis)</li>
          <li>Prevention of Wernicke's before glucose administration in high-risk patients</li>
          <li>Metabolic emergencies (e.g., lactic acidosis from suspected thiamine deficiency)</li>
        </ul>

        <div class="rule"></div>

        <h3>Contraindications / cautions</h3>
        <ul>
          <li>Hypersensitivity to thiamine (rare but can cause anaphylaxis with rapid IV administration)</li>
          <li>Administer slowly if IV route used; IM route preferred if anaphylaxis risk concern</li>
          <li>No absolute contraindications in emergency Wernicke's treatment—benefits outweigh risks</li>
          <li>Large doses are generally well-tolerated; excess thiamine is renally excreted</li>
        </ul>

        <div class="rule"></div>

        <h3>Adverse effects</h3>
        <ul>
          <li>Generally well-tolerated</li>
          <li>Rare: hypersensitivity reactions (pruritus, urticaria), anaphylaxis (very rare, more common with rapid IV bolus)</li>
          <li>Local irritation at IM injection site</li>
        </ul>

        <div class="rule"></div>

        <h3>Preparation &amp; administration</h3>
        <ul>
          <li>IM injection: administer into large muscle (gluteal or deltoid); 100 mg/mL concentration</li>
          <li>IV route: dilute in 50–100 mL normal saline or D5W and infuse over 30 minutes to reduce hypersensitivity risk; IM route safer if IV monitoring limited</li>
          <li>In suspected Wernicke's: give thiamine FIRST, then IV dextrose (not the reverse)</li>
          <li>Store at room temperature; protect from light</li>
        </ul>

        <div class="rule"></div>

        <h3>Monitoring</h3>
        <ul>
          <li>Clinical response: improvement in confusion, ataxia, eye movement abnormalities (Wernicke's signs)</li>
          <li>Monitor for hypersensitivity reaction during/after administration (especially first dose IV)</li>
          <li>Neurological exam repeated over hours-to-days to assess response</li>
          <li>If prolonged therapy required, monitor nutritional status and consider transition to oral thiamine when feasible</li>
        </ul>

        <div class="rule"></div>

        <h3>At-sea considerations</h3>
        <ul>
          <li>Low threshold to give thiamine in altered mental status + known/suspected alcohol use or malnutrition—early treatment critical</li>
          <li>Document triad: confusion/AMS, ataxia, ophthalmoplegia (Wernicke's), but absence of full triad does not exclude diagnosis</li>
          <li>Always give thiamine BEFORE glucose in at-risk patients to prevent precipitating Wernicke's</li>
          <li>IM route is practical and safer onboard if IV infusion monitoring is limited; anaphylaxis risk very low</li>
          <li>If limited diagnostic capability, treat empirically in high-risk presentations and arrange timely evacuation if no improvement</li>
        </ul>

        <div class="rule"></div>

        <h3>Online-only references</h3>
        <ul>
          <li>Health Canada product monograph (thiamine hydrochloride injection): <a href="https://pdf.hres.ca/dpd_pm/00068718.PDF" target="_blank" rel="noopener">https://pdf.hres.ca/dpd_pm/00068718.PDF</a></li>
          <li>Medscape reference (Wernicke encephalopathy): <a href="https://emedicine.medscape.com/article/794583-overview" target="_blank" rel="noopener">https://emedicine.medscape.com/article/794583-overview</a></li>
          <li>RxFiles Drug Comparison (thiamine dosing summary): <a href="https://www.rxfiles.ca" target="_blank" rel="noopener">https://www.rxfiles.ca</a></li>
        </ul>
      </div>

      <p class="foot">
        Verify dosing and indications against current clinical guidelines.
      </p>
    </section>
  </main>
</body>
</html>
